HomeLENZ • NASDAQ
add
Lenz Therapeutics Inc
Previous close
$26.72
Day range
$26.33 - $27.84
Year range
$16.54 - $50.19
Market cap
825.74M USD
Avg Volume
1.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 12.50M | — |
Operating expense | 31.39M | 142.46% |
Net income | -16.70M | -63.49% |
Net profit margin | -133.60 | — |
Earnings per share | -0.59 | -55.26% |
EBITDA | -18.76M | -45.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 202.17M | -6.88% |
Total assets | 210.70M | -5.94% |
Total liabilities | 16.78M | 92.24% |
Total equity | 193.93M | — |
Shares outstanding | 31.29M | — |
Price to book | 3.94 | — |
Return on assets | -22.06% | — |
Return on capital | -23.47% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -16.70M | -63.49% |
Cash from operations | -8.59M | 18.84% |
Cash from investing | -4.33M | 93.04% |
Cash from financing | 598.00K | -97.99% |
Net change in cash | -12.32M | 71.33% |
Free cash flow | -3.48M | 52.16% |
About
Founded
2013
Headquarters
Website
Employees
42
